Vasoconstrictor effect and mechanism of action of endothelin-1 in human radial artery and vein: Implication of skin flap vasospasm

被引:8
作者
Black, CE
Huang, N
Neligan, PC
Forrest, CR
Lipa, JE
Pang, CY
机构
[1] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Surg, Toronto, ON, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
ETA receptors; L-type Ca2+ channels; intracellular Ca2+; protein kinase C; radial artery and vein;
D O I
10.1097/00005344-200303000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasospasm in the vascular pedicle is a major cause of ischemic necrosis in autogenous skin transplantation (i.e., skin free flap surgery), and the pathophysiology is unclear. The clinical impression is that veins are more susceptible to vasospasm than arteries in the vascular pedicle of skin free flaps. The purpose of this study was to compare the vasoconstrictor response of the human radial artery (RA) and radial vein (RV) to endothelin (ET)-1 and to investigate the mechanism mediating ET-1-induced vasoconstriction. The isometric tension of RA and RV rings (4 mm) obtained from the vascular pedicle of human radial forearm skin free flaps were studied in organ chambers containing Krebs bicarbonate buffer. It was observed that ET-1 elicited concentration-dependent (5 x 10(-11) to 2 x 10(-8) M contractions in RA and RV rings with similar contractile potency. However, the concentration-dependent contractile response to ET-1 was significantly (P < 0.05) higher in RV rings than in RA rings, with the maximum contractile response twice as high in RV rings than in RA rings. The contractile response to ET-1 in RA and RV rings was blocked by the ETA receptor antagonist BQ 123 (10(-5) M), but not by the ETB receptor antagonist BQ 788 (5 x 10(-6) M). The ETB receptor agonist BQ 3020 (10(-10) to 2 x 10(-8) M had no significant contractile effect in RA and RV rings. Furthermore, the L-type Ca2+ channel antagonist nifedipine (5 x 10(-6) M), the protein kinase C (PKC) inhibitor chelerythrine (10(-5) M), and the intracellular Ca2+ chelator BAPTA-AM (10(-5) M) significantly reduced the contractile potency of ET-1 in RA rings and the maximum contractile response to ET-1 in RA and RV rings. It was concluded that the human RV is more responsive than RA to the contractile effect of ET-1. The contractile response to ET-1 in RA and RV is predominantly mediated by ETA receptors and the postreceptor mechanism involves L-type Ca2+ channels, PKC, and intracellular Ca2+.
引用
收藏
页码:460 / 467
页数:8
相关论文
共 26 条
  • [1] Afridi N.S., 2000, CAN J PLAST SURG, V8, P30, DOI [10.1177/229255030000800103, DOI 10.1177/229255030000800103]
  • [2] THE EFFECT OF PRIOR ELEVATION OF SKIN FLAPS AND ISCHEMIA ON BLOOD THROMBOXANE LEVELS
    ANGEL, MF
    KNIGHT, KR
    MELLOW, CG
    MORRISON, WA
    OBRIEN, BM
    [J]. ANNALS OF PLASTIC SURGERY, 1989, 22 (06) : 501 - 504
  • [3] Daniel RK., 1990, PLAST SURG-CHIR PLAS, V1, P275
  • [4] DOHERTY AM, 1995, CHEM STRUCTURAL APPR, P85
  • [5] EFFECT OF ISCHEMIC SKIN FLAP ELEVATION ON TISSUE AND PLASMA THROMBOXANE-A2 AND PROSTACYCLIN PRODUCTION - MODIFICATION BY THROMBOXANE SYNTHETASE INHIBITION
    EDSTROM, LE
    BALKOVICH, M
    SLOTMAN, GJ
    [J]. ANNALS OF PLASTIC SURGERY, 1988, 20 (02) : 106 - 111
  • [6] FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P146
  • [7] Endothelin as a regulator of cardiovascular function in health and disease
    Haynes, WG
    Webb, DJ
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (08) : 1081 - 1098
  • [8] Comparison of secondary ischemic tolerance between pedicled and free island buttock skin flaps in the pig
    He, W
    Neligan, P
    Lipa, J
    Forrest, C
    Pang, CY
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1997, 100 (01) : 72 - 81
  • [9] Microsurgery costs and outcome
    Heinz, TR
    Cowper, PA
    Levin, LS
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 104 (01) : 89 - 96
  • [10] Changes in endothelin-1, 6-keto-PG-F1α, and TX-B2 in random pattern flaps
    Inoue, H
    Aihara, M
    Tomioka, M
    Ishida, H
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S477 - S479